Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation
Shinsuke Miyazaki(Yokosuka Kyosai Hospital), Atsushi Takahashi(Juntendo University), A. Kobori(Yokosuka Kyosai Hospital), Atsushi Takei(Yokosuka Kyosai Hospital), Yoshihide Takahashi(Rutgers, The State University of New Jersey), Mitsuaki Isobe(Sakakibara Hospital), Taishi Kuwahara(Kurume University), Akira Sato(Unknown)
Cited by 13
Related Papers
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
|Thrombosis and Haemostasis|2021|476
Wnt5a regulates distinct signalling pathways by binding to Frizzled2
|The EMBO Journal|2009|319
Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome
|Circulation|2006|292
Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26
|Clinical Infectious Diseases|2007|222